Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Price LSL"'
Autor:
Baines AC; United States Food and Drug Administration, Silver Spring, MD, United States., Kanapuru B; United States Food and Drug Administration, Silver Spring, MD, United States., Zhao J; United States Food and Drug Administration, Silver Spring, MD, United States., Price LSL; United States Food and Drug Administration, Silver Spring, United States., Zheng N; United States Food and Drug Administration, Silver Spring, MD, United States., Konicki R; United States Food and Drug Administration, Silver Spring, MD, United States., Manning ML; United States Food and Drug Administration, Silver Spring, Maryland, United States., Gehrke BJ; Food and Drug Administration, White Oak, MD, United States., Theoret MR; Food and Drug Administration, Silver Spring, MD, United States., Gormley NJ; United States Food and Drug Administration, Silver Spring, MD, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.
Autor:
Duke ES; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bradford D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Marcovitz M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amatya AK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Mishra-Kalyani PS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Nguyen E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Price LSL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fourie Zirkelbach J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bi Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kraft J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Dorff SE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Scepura B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Stephenson M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ojofeitimi I; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Nair A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Han Y; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Tezak Z; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Lemery SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Larkins E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Singh H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 15; Vol. 29 (18), pp. 3573-3578.
Autor:
Pulte ED; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Chen H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Price LSL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Gudi R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Li H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Okusanya OO; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Ma L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Rodriguez L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Vallejo J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Norsworthy KJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
The oncologist [Oncologist] 2022 Mar 04; Vol. 27 (2), pp. 149-157.
Autor:
Price LSL; Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA., Rivera JN; Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC, USA., Madden AJ; Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA., Herity LB; Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA., Piscitelli JA; Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA., Mageau S; Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA., Santos CM; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Roques JR; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Midkiff B; Translational Pathology Lab, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Feinberg NN; Translational Pathology Lab, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Darr D; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Chang SX; Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC, USA., Zamboni WC; Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 1022B Genetic Medicine Building, 120 Mason Farm Road, Campus Box 7361, Chapel Hill, NC 27599-7361, USA.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 Oct 29; Vol. 13, pp. 17588359211053700. Date of Electronic Publication: 2021 Oct 29 (Print Publication: 2021).
Autor:
Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Price LSL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Okusanya OO; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Li RJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ma L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Wu YT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
The oncologist [Oncologist] 2021 Oct; Vol. 26 (10), pp. 879-886. Date of Electronic Publication: 2021 Jul 01.
Autor:
Bradford D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. diana.bradford@fda.hhs.gov., Larkins E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Mushti SL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rodriguez L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Skinner AM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Helms WS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Price LSL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zirkelbach JF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Liu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Turcu FR; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Liang D; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Ghosh S; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Roscoe D; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Philip R; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Zack-Taylor A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Singh H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Apr 15; Vol. 27 (8), pp. 2130-2135. Date of Electronic Publication: 2020 Nov 25.
Autor:
Sager JE; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA., Tripathy S; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA., Price LSL; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA., Nath A; Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, USA., Chang J; Department of Obstetrics and Gynecology, School of Medicine, University of Washington, Seattle, WA, USA., Stephenson-Famy A; Department of Obstetrics and Gynecology, School of Medicine, University of Washington, Seattle, WA, USA., Isoherranen N; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA. Electronic address: ni2@uw.edu.
Publikováno v:
Biochemical pharmacology [Biochem Pharmacol] 2021 Jan; Vol. 183, pp. 114306. Date of Electronic Publication: 2020 Nov 05.
Autor:
Price LSL; Carolina Center of Cancer Nanotechnology Excellence (C-CCNE), University of North Carolina, Chapel Hill, NC, USA.; Translational Oncology and Nanoparticle Drug Development (TOND2I) Lab, University of North Carolina, Chapel Hill, NC, USA., Stern ST; Nanotechnology Characterization Lab (NCL), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Deal AM; UNC Lineberger Biostatistics Shared Resource, Chapel Hill, NC, USA., Kabanov AV; Carolina Center of Cancer Nanotechnology Excellence (C-CCNE), University of North Carolina, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Carolina Institute for Nanomedicine, University of North Carolina, Chapel Hill, NC, USA., Zamboni WC; Carolina Center of Cancer Nanotechnology Excellence (C-CCNE), University of North Carolina, Chapel Hill, NC, USA.; Translational Oncology and Nanoparticle Drug Development (TOND2I) Lab, University of North Carolina, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Carolina Institute for Nanomedicine, University of North Carolina, Chapel Hill, NC, USA.
Publikováno v:
Science advances [Sci Adv] 2020 Jul 15; Vol. 6 (29), pp. eaay9249. Date of Electronic Publication: 2020 Jul 15 (Print Publication: 2020).
Autor:
McSweeney MD; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: morgan_mcsweeney@unc.edu., Price LSL; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Wessler T; Department of Mathematics, University of North Carolina, Chapel Hill, NC, USA., Ciociola EC; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: liz_ciociola@med.unc.edu., Herity LB; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: herity@email.unc.edu., Piscitelli JA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: joseph_piscitelli@unc.edu., DeWalle AC; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: adewalle@live.unc.edu., Harris TN; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: taylornh@email.unc.edu., Chan AKP; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: kwan.chan.13@alumni.ucl.ac.uk., Saw RS; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ran.saw.14@alumni.ucl.ac.uk., Hu P; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: peiqi_hu@med.unc.edu., Jennette JC; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: charles_jennette@med.unc.edu., Forest MG; Department of Mathematics, University of North Carolina, Chapel Hill, NC, USA. Electronic address: forest@unc.edu., Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: yanguang@unc.edu., Montgomery SA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA; Lineburger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: stephanie_montgomery@med.unc.edu., Zamboni WC; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: zamboni@email.unc.edu., Lai SK; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; UNC/NCSU Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: lai@unc.edu.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2019 Oct; Vol. 311-312, pp. 138-146. Date of Electronic Publication: 2019 Aug 24.
Autor:
McSweeney MD; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: morgan_mcsweeney@unc.edu., Wessler T; Department of Mathematics, University of North Carolina, Chapel Hill, NC, USA. Electronic address: wessler@live.unc.edu., Price LSL; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: lslprice@email.unc.edu., Ciociola EC; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: lciociol@live.unc.edu., Herity LB; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: herity@email.unc.edu., Piscitelli JA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: joseph_piscitelli@unc.edu., Zamboni WC; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: zamboni@email.unc.edu., Forest MG; Department of Mathematics, University of North Carolina, Chapel Hill, NC, USA. Electronic address: forest@unc.edu., Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: yanguang@unc.edu., Lai SK; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; UNC/NCSU Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: lai@unc.edu.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2018 Aug 28; Vol. 284, pp. 171-178. Date of Electronic Publication: 2018 Jun 05.